Dr. Reeder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5777 E Mayo Blvd
Phoenix, AZ 85054Phone+1 480-515-6296
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1981 - 1983
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1978 - 1981
- Southern Illinois University School of MedicineClass of 1978
Certifications & Licensure
- AZ State Medical License 1986 - 2025
- CA State Medical License 1983 - 2025
- MN State Medical License 1979 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma Start of enrollment: 2003 Jul 01
- Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2005 Jun 01
- Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2006 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsPhase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemiaKevin R. Kelly, Thomas C. Shea, Andre Goy, Jesus G. Berdeja, Craig B. Reeder
Investigational New Drugs. 2014-06-01 - 948 citationsLenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.Alan F. List, Gordon W. Dewald, John M. Bennett, A. Giagounidis, Azra Raza
The New England Journal of Medicine. 2006-10-05 - 19 citationsPhase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.Shaji Kumar, Joseph R. Mikhael, Betsy LaPlant, Martha Q. Lacy, Francis K. Buadi
Bone Marrow Transplantation. 2014-02-01
Journal Articles
- Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
- Phase I Study of Pomalidomide and Dexamethasone for relapsed/refractory Primary CNS or Vitreo-Retinal LymphomaLisa M DeAngelis, Han W Tun, David Schiff, Kurt A Jaeckle, Christian Grommes, Patrick B Johnston, Craig B Reeder, Thomas E Witzig, Blood
Abstracts/Posters
- The DIAL Study (Dual Immunomodulation in Aggressive Lymphoma): A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination with Nivolumab in Patients with Relap...Craig B. Reeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long Non-Coding RNA Expression in Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined SignificanceCraig B. Reeder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Phoenix Dermatologist & Oncologist Honored for Providing Collaborative Care to Patient with Rare CancerMarch 25th, 2020
- Amyloidosis Support GroupsJuly 24th, 2019
- Mayo Clinic Researchers Identify TherapyMarch 9th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: